Addressing Severe Itching in PFIC2 Patients

One of the most distressing symptoms of Progressive Familial Intrahepatic Cholestasis Type 2 is intense pruritus. This symptom significantly affects sleep, emotional well-being, and overall quality of life. Effective management of itching is therefore a primary therapeutic goal.

Medications targeting bile acid pathways have become central in treatment. By reducing bile acid accumulation in the bloodstream, these therapies help decrease itch severity. Rifampicin and bile acid sequestrants have been used traditionally, while newer IBAT inhibitors offer more targeted relief.

Non-pharmacological approaches, including skin care routines and cooling strategies, may provide supplementary comfort. In refractory cases, surgical diversion techniques can reduce bile acid levels more dramatically.

Ref - https://www.marketresearchfuture.com/reports/progressive-familial-intrahepatic-cholestasis-type-2-treatment-market-27160